SBRI funding competition - vaccines for global epidemics (clinical)
This is a Small Business Research Initiative (SBRI) competition run in partnership with the United Kingdom Department of Health and the Medical Research Council. It aims to support the clinical development of candidate vaccines against 12 diseases. The UK Vaccine Network has identified these diseases as a priority because they have the potential to cause epidemics in low- and middle-income countries (LMICs).
12 Apr 2017
£35,000,000 (thirty five million pounds) have been allocated for the clinical development of vaccines up to and including phase IIb trials.
While it is expected that individual contracts will be worth up to £3,000,000 (three million pounds), they will consider making larger awards on a case-by-case basis.
If the Department of Health does not distribute the entire £35,000,000 available, the competition will reopen in 2018.
OTHER KEY DATES
Competition opens Monday 23: January 2017
Registration deadline: Midday (12.00pm) on Wednesday 12 April 2017
Application deadline: Midday (12.00pm) on Wednesday 19 April 2017
Projects are expected to last between 24 and 36 months.
Note that while some organisers may accept applications from all around the world, you may still be required to travel to the host country in order to take part in the later stages of a competition for instance, or you may be required to live there for a period of time to take part in a funded programme (e.g. scholarship, incubator, accelerator).
Credit: SBRI funding competition - vaccines for global epidemics (clinical)
Want up to 10 recommended opportunities sent to you once a quarter for free? GET COMPETITIONS
The Scale-up Hub launched by Wayra UK, Innogy Innovation Hub. Hyundai and Transport Systems Catapult, is a London-based programme which is focussed on supporting high growth companies (scale-ups) within the smart energy, smart cities and IoT sectors.....